Latest Degarelix Stories

2013-11-20 23:27:39

MarketResearchReports.Biz announces addition of new report “Prostate Cancer Therapeutics Market to 2019 ” to its database.

2012-04-09 05:40:35

Do you or someone you know suffer from advanced prostate cancer (CRPC)? A new treatment may be available that can help treat the deadly disease.

2012-04-05 13:47:02

Men experience a marked drop in their testosterone levels when taking a targeted therapy to control a specific type of lung cancer.

2012-04-02 09:22:59

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer (CRPC) in a Phase 1 study.

2012-04-02 09:16:50

Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug.

Word of the Day
  • A political dynamiter.
The word 'dynamitard' is related to 'dynamite', which comes from a Greek root meaning 'power' and was coined by Alfred Nobel.